These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2881497)

  • 1. Drug interactions in surgical patients.
    May JR; DiPiro JT; Sisley JF
    Am J Surg; 1987 Mar; 153(3):327-35. PubMed ID: 2881497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of cardiac glycoside drug interactions.
    Hooymans PM; Merkus FW
    Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of moricizine.
    Siddoway LA; Schwartz SL; Barbey JT; Woosley RL
    Am J Cardiol; 1990 Feb; 65(8):21D-25D; discussion 68D-71D. PubMed ID: 2407090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of H2-receptor antagonists on drug interaction in rats.
    Lin JH; Cocchetto DM; Yeh KC; Duggan DE
    Drug Metab Dispos; 1986; 14(6):649-53. PubMed ID: 2877821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine H2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications.
    Powell JR; Donn KH
    Am J Med; 1984 Nov; 77(5B):57-84. PubMed ID: 6150639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential drug interactions in surgical patients.
    Durrence CW; DiPiro JT; May JR; Nesbit RR; Sisley JF; Cooper JW
    Am J Hosp Pharm; 1985 Jul; 42(7):1553-6. PubMed ID: 4025352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists--adverse drug interactions.
    Reicher-Reiss H; Neufeld HN; Ebner FX
    Cardiovasc Drugs Ther; 1987 Dec; 1(4):403-9. PubMed ID: 2908714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic agents: drug interactions of clinical significance.
    Trujillo TC; Nolan PE
    Drug Saf; 2000 Dec; 23(6):509-32. PubMed ID: 11144659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions and non-interactions with ranitidine.
    Kirch W; Hoensch H; Janisch HD
    Clin Pharmacokinet; 1984; 9(6):493-510. PubMed ID: 6096071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serious drug interactions.
    Aronson J
    Practitioner; 1993 Oct; 237(1531):789-91. PubMed ID: 7903448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug interactions and clinical relevance: it all began with cheese].
    Carrillo Norte JA
    Rev Enferm; 2012 Apr; 35(4):8-18. PubMed ID: 22745995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the safety profile of the H2-receptor antagonists.
    Hansten PD
    DICP; 1990 Nov; 24(11 Suppl):S38-41. PubMed ID: 1980183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions with oral contraceptives.
    Fotherby K
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2153-9. PubMed ID: 2256524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interactions with nitrendipine.
    Kirch W; Hutt HJ; Heidemann H; Rämsch K; Janisch HD; Ohnhaus EE
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S982-5. PubMed ID: 6085389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic drug interactions in anaesthetic practice.
    Wood M
    Clin Pharmacokinet; 1991 Oct; 21(4):285-307. PubMed ID: 1760901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interactions of the macrolide antibiotics.
    Ludden TM
    Clin Pharmacokinet; 1985; 10(1):63-79. PubMed ID: 3882305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
    Lin JH
    Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety: cimetidine and concomitant theophylline or warfarin--drug interactions and their implications.
    Frank WO
    Clin Ther; 1986; 8 Suppl A():57-68. PubMed ID: 2878729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low potential for interactions between melagatran/ximelagatran and other drugs, food, or alcohol.
    Wolzt M; Sarich TS; Eriksson UG
    Semin Vasc Med; 2005 Aug; 5(3):254-8. PubMed ID: 16123912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.